|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/10 | |
| A61K 38/00 | |||
| A61K 38/12 | |||
| A61P 1/10 |
| (11) | Number of the document | 3054969 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14851594.3 |
| Date of filing the European patent application | 2014-10-10 | |
| (97) | Date of publication of the European application | 2016-08-17 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/060157 |
| Date | 2014-10-10 |
| (87) | Number | WO 2015/054649 |
| Date | 2015-04-16 |
| (30) | Number | Date | Country code |
| 201361889308 P | 2013-10-10 | US |
| (72) |
SHAILUBHAI, Kunwar, US
PALEJWALA, Vaseem, US
|
| (73) |
Bausch Health Ireland Limited,
3013 Lake Drive Citywest Business Campus, Dublin 24,
IE
|
| (54) | AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF OPIOID INDUCED DYSFUNCTIONS |
| AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF OPIOID INDUCED DYSFUNCTIONS |